Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT MELOXICAM | 7.5MG | TABLET | Actual shortage | 2020-01-09 | 2020-01-09 | 102935 |
NOVAMOXIN | 250MG | CAPSULE | Resolved | 2020-01-09 | 2020-01-24 | 102938 |
ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-09 | 2020-05-29 | 102945 |
TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-08-21 | 103510 |
TEVA-BROMAZEPAM | 3MG | TABLET | Resolved | 2020-01-17 | 2020-02-07 | 103552 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-01-17 | 2020-04-02 | 103555 |
TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2020-01-17 | 2020-03-12 | 103558 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-01-17 | 2020-01-25 | 103561 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-01-30 | 103566 |
TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2020-01-17 | 2020-02-07 | 103569 |
TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2020-01-17 | 2020-04-02 | 103572 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-01-17 | 2020-01-30 | 103578 |
TEVA-METFORMIN | 850MG | TABLET | Resolved | 2020-01-17 | 2020-10-22 | 103584 |
TEVA-RASAGILINE | 0.5MG | TABLET | Resolved | 2020-01-17 | 2020-06-04 | 103587 |
TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2020-01-17 | 2020-06-18 | 103590 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2020-01-17 | 2020-02-07 | 103593 |
TEVA-DILTIAZEM | 60MG | TABLET | Actual shortage | 2020-01-21 | 2020-01-21 | 103773 |
TEVA-TERAZOSIN | 2MG | TABLET | Actual shortage | 2020-01-21 | 2020-01-21 | 103776 |
TEVA-SELEGILINE | 5MG | TABLET | Actual shortage | 2020-01-21 | 2020-01-21 | 103814 |
ACT RANITIDINE | 150MG | TABLET | Resolved | 2020-01-24 | 2020-05-14 | 104307 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |